13F-HR filed by Vida Ventures Advisors, LLC
Vida Ventures Advisors, LLC filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-01-05, with 7 holding rows worth $83,997,648.
- Accession
- 0000950123-24-000049
- Filer
- CIK 1831423
- Filed
- 2024-01-05
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 7 entries on the cover page, a total value of $83,997,648 stated on the cover page (in dollars after the unit check, H1), rows summing to $83,997,648 with VALUE read as dollars as filed, 13F file number 028-20380. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 3,931,818 | $31,297,271 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,074,787 | $27,594,667 | dollars as filed | |
| LIANBIO ADR | 53000N108 | COM | 2,282,084 | $10,200,916 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 1,798,163 | $5,772,103 | dollars as filed | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 2,207,772 | $5,232,420 | dollars as filed | |
| KRONOS BIO INC | 50107A104 | COM | 2,765,314 | $3,456,643 | dollars as filed | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 225,192 | $443,628 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-24-000049 | this filing | 2024-01-05 | acceptance time not in the bulk data set |